Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Br J Psychiatry. 2018 Oct 25;213(6):704–708. doi: 10.1192/bjp.2018.211

Table 1.

Pre-treatment patient characteristics by treatment condition.

Patient Characteristics PE (n = 77) M (SD) or % Sertraline (n = 57) M (SD) or %
Age (years) 36.61 (11.55) 39.72 (12.01)
Gender (% Female) 83.1% 73.7%
Ethnicity (% Caucasian) 71.4% 71.9%
Time Since Trauma (years) 12.23 (12.24) 12.58 (13.67)
Target Trauma Type
    Adult Sexual Assault 33.8% 31.6%
    Childhood Assault (e.g., CSA) 24.7% 21.1%
    Adult Assault (non-sexual) 19.5% 22.8%
    Accident or Natural Disaster 15.6% 15.8%
    Death/Violence to Loved One 3.9% 7.0%
    Combat/War 2.6% 1.8%
PTSD Severity (PSS-I) 29.53 (6.83) 29.70 (6.82)
State Anxiety (STAI-S) 55.29 (11.36) 57.03 (11.73)
Depression (BDI) 24.09 (9.00) 27.17 (9.89)
Expectancy of Therapeutic Outcome (ETO) 24.51 (5.09) 23.52 (6.09)

Note. PE = prolonged exposure; CSA = childhood sexual assault; MVA = motor vehicle accident; ETO n = 126. PSS-I = PTSD Symptom Scale - Interview; STAI-S = State-Trait Anxiety Inventory - State; BDI = Beck Depression Inventory; ETO = Expectancy of Therapeutic Outcome.